Tandem Diabetes (TNDM) Tops Q4 EPS by 9c, Revenues Miss; Offers FY20 Revenue Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. CBRS
2. KBH
3. FDX
4. HONA
5. HTZ
6. HON
7. TTWO
8. HELP
9. GDYN
10. NKE

Go back to Tandem Diabetes (TNDM) Tops Q4 EPS by 9c, Revenues Miss; Offers FY20 Revenue Guidance Above Consensus

Tandem Diabetes Care (TNDM) PT Raised to $82 at Baird

February 21, 2020 8:16 AM EST

Baird analyst Jeff Johnson raised the price target on Tandem Diabetes Care (NASDAQ: TNDM) to $82.00 (from $75.00) while maintaining a Neutral rating.... More